{"id":25818,"date":"2022-05-03T11:48:08","date_gmt":"2022-05-03T15:48:08","guid":{"rendered":"https:\/\/avalere.com\/?p=25818"},"modified":"2023-06-08T17:39:17","modified_gmt":"2023-06-08T21:39:17","slug":"navigating-the-evolving-cell-gene-therapy-market","status":"publish","type":"post","link":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market","title":{"rendered":"The Evolving Cell &#038; Gene Therapy Market\u202f\u202f\u202f"},"content":{"rendered":"<p>With 8 cell and gene therapies on the market, over 450 unique products in clinical development, and 50 approvals expected by 2030, the CGT market is growing rapidly.<\/p>\n<p>Products currently in clinical development include autologous and allogeneic cell therapies and in-vivo and ex-vivo gene therapies administered across settings of care (i.e., inpatient, HOPD, physician office, and pharmacy) with indications for oncology, metabolic disorders, hematology, rare disease, and other various diseases.<\/p>\n<p>Join our webinar, which dives into how to overcome challenges that this significant pipeline presents for stakeholders such as:<\/p>\n<ul style=\"margin-bottom: 30px;\">\n<li>Limitations related to small clinical trial populations<\/li>\n<li>Current reimbursement frameworks<\/li>\n<li>Budget impacts<\/li>\n<li>Narrow sites of care<\/li>\n<li>Manufacturing inefficiencies that will have implications for the broader healthcare system<\/li>\n<\/ul>\n<p>We will also cover ways to help stakeholders looking to reimagine FDA-approval processes, develop innovative financing solutions, and standardize manufacturing to optimize time to treatment.<\/p>\n<p>We look forward to seeing you there!<\/p>\n","protected":false},"excerpt":{"rendered":"<p>With 8 cell and gene therapies on the market, over 450 unique products in clinical development, and 50 approvals expected by 2030, the CGT market is growing rapidly. Products currently in clinical development include autologous and allogeneic cell therapies and in-vivo and ex-vivo gene therapies administered across settings of care (i.e., inpatient, HOPD, physician office,&hellip;<\/p>\n","protected":false},"author":17,"featured_media":25588,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[6],"tags":[],"content-categories":[991],"class_list":["post-25818","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-webinars","content-categories-cell-and-gene-therapy","entry","has-media"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Evolving Cell &amp; Gene Therapy Market\u202f\u202f\u202f | Avalere Health Advisory<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Evolving Cell &amp; Gene Therapy Market\u202f\u202f\u202f | Avalere Health Advisory\" \/>\n<meta property=\"og:description\" content=\"With 8 cell and gene therapies on the market, over 450 unique products in clinical development, and 50 approvals expected by 2030, the CGT market is growing rapidly. Products currently in clinical development include autologous and allogeneic cell therapies and in-vivo and ex-vivo gene therapies administered across settings of care (i.e., inpatient, HOPD, physician office,&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market\" \/>\n<meta property=\"og:site_name\" content=\"Avalere Health Advisory\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-03T15:48:08+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-08T21:39:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/04\/3180-1-Megan_West-400x600-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cturner\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@avalerehealth\" \/>\n<meta name=\"twitter:site\" content=\"@avalerehealth\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"cturner\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Evolving Cell & Gene Therapy Market\u202f\u202f\u202f | Avalere Health Advisory","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market","og_locale":"en_US","og_type":"article","og_title":"The Evolving Cell & Gene Therapy Market\u202f\u202f\u202f | Avalere Health Advisory","og_description":"With 8 cell and gene therapies on the market, over 450 unique products in clinical development, and 50 approvals expected by 2030, the CGT market is growing rapidly. Products currently in clinical development include autologous and allogeneic cell therapies and in-vivo and ex-vivo gene therapies administered across settings of care (i.e., inpatient, HOPD, physician office,&hellip;","og_url":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market","og_site_name":"Avalere Health Advisory","article_published_time":"2022-05-03T15:48:08+00:00","article_modified_time":"2023-06-08T21:39:17+00:00","og_image":[{"width":600,"height":400,"url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/04\/3180-1-Megan_West-400x600-1.jpg","type":"image\/jpeg"}],"author":"cturner","twitter_card":"summary_large_image","twitter_creator":"@avalerehealth","twitter_site":"@avalerehealth","twitter_misc":{"Written by":"cturner","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market#article","isPartOf":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market"},"author":{"name":"cturner","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/person\/8cbb93ca150560eaa45e177128d2a9a9"},"headline":"The Evolving Cell &#038; Gene Therapy Market\u202f\u202f\u202f","datePublished":"2022-05-03T15:48:08+00:00","dateModified":"2023-06-08T21:39:17+00:00","mainEntityOfPage":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market"},"wordCount":151,"commentCount":0,"publisher":{"@id":"https:\/\/advisory.avalerehealth.com\/#organization"},"image":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market#primaryimage"},"thumbnailUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/04\/3180-1-Megan_West-400x600-1.jpg","articleSection":["Webinars"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market#respond"]}]},{"@type":"WebPage","@id":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market","url":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market","name":"The Evolving Cell & Gene Therapy Market\u202f\u202f\u202f | Avalere Health Advisory","isPartOf":{"@id":"https:\/\/advisory.avalerehealth.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market#primaryimage"},"image":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market#primaryimage"},"thumbnailUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/04\/3180-1-Megan_West-400x600-1.jpg","datePublished":"2022-05-03T15:48:08+00:00","dateModified":"2023-06-08T21:39:17+00:00","breadcrumb":{"@id":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market#primaryimage","url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/04\/3180-1-Megan_West-400x600-1.jpg","contentUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2022\/04\/3180-1-Megan_West-400x600-1.jpg","width":600,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/advisory.avalerehealth.com\/webinars\/navigating-the-evolving-cell-gene-therapy-market#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/advisory.avalerehealth.com\/"},{"@type":"ListItem","position":2,"name":"The Evolving Cell & Gene Therapy Market\u202f\u202f\u202f"}]},{"@type":"WebSite","@id":"https:\/\/advisory.avalerehealth.com\/#website","url":"https:\/\/advisory.avalerehealth.com\/","name":"Avalere Health Advisory","description":"","publisher":{"@id":"https:\/\/advisory.avalerehealth.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/advisory.avalerehealth.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/advisory.avalerehealth.com\/#organization","name":"Avalere Health","url":"https:\/\/advisory.avalerehealth.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/logo\/image\/","url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2025\/03\/avalere-health-logo-cropped-white_1x.webp","contentUrl":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2025\/03\/avalere-health-logo-cropped-white_1x.webp","width":433,"height":47,"caption":"Avalere Health"},"image":{"@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/avalerehealth"]},{"@type":"Person","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/person\/8cbb93ca150560eaa45e177128d2a9a9","name":"cturner","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/advisory.avalerehealth.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fbae6a0a1ad4084cd85b62cfb6863eee?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fbae6a0a1ad4084cd85b62cfb6863eee?s=96&d=mm&r=g","caption":"cturner"},"url":"https:\/\/advisory.avalerehealth.com\/author\/cturner"}]}},"_links":{"self":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts\/25818","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/users\/17"}],"replies":[{"embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/comments?post=25818"}],"version-history":[{"count":16,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts\/25818\/revisions"}],"predecessor-version":[{"id":29315,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/posts\/25818\/revisions\/29315"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/media\/25588"}],"wp:attachment":[{"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/media?parent=25818"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/categories?post=25818"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/tags?post=25818"},{"taxonomy":"content-categories","embeddable":true,"href":"https:\/\/advisory.avalerehealth.com\/wp-json\/wp\/v2\/content-categories?post=25818"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}